Tag: ARVs

  • Pharmaceutical Manufacturing Crisis Deepens

    South Africa’s pharmaceutical manufacturing crisis is growing as local producers lose government contracts and contend with rising costs. Stavros Nicolaou, chair of Pharmaceuticals Made in South Africa, says the Department of Health’s procurement policy is undermining the government’s localisation ambitions. He notes that officials award contracts to companies labelled as local suppliers. However, some companies import finished medicines rather than…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Barrs Pharmaceuticals Secures R92m Hetero Investment

    Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure. Business rescue consultant Karl Gribnitz announced that the Indian generics group’s South African subsidiary will acquire 78% of Barrs for R92m. The group intends this investment to…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • HIV ARV Tender Crisis Triggers Parliamentary Scrutiny

    Health Minister Aaron Motsoaledi faces urgent questions in Parliament after two companies holding major government contracts to supply HIV medicines entered business rescue. The concern is immediate and practical. Any disruption to antiretroviral (ARV) supply can lead to missed doses. That raises the risk of treatment failure and drug resistance. South Africa carries the world’s biggest HIV burden. An estimated…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • WhatsApp Microlearning: Solving a Persistent HIV Training Gap

    A new approach to frontline training is gaining traction in South Africa’s HIV response. It is built around a simple idea. Most clinicians and counsellors may not have time for long online webinars, but they do have phones and use WhatsApp. Briony Chisholm, an information pharmacist at the University of Cape Town’s Medicines Information Centre (MIC), says rural clinics often…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • ARV Supply Reassurance After Business Rescue Reports

    The National Department of Health has moved to reassure stakeholders about antiretroviral (ARV) shortages after reports that two suppliers in the current ARV tender have entered business rescue. Department spokesperson Foster Mohale said the country is not facing a supply crisis and that contingency plans are already in motion. Mohale said supply disruptions linked to financially distressed suppliers are not…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Pharma Giants Sidelined in R15.5bn HIV Drug Tender

    The National Department of Health has awarded its latest three-year antiretroviral (ARV) tender, valued at R15.5 billion. This decision leaves several of South Africa’s largest domestic pharmaceutical manufacturers without a contract. The government’s procurement strategy sidelines pharma giants and sparks a fresh debate. This debate pits aggressive cost-saving measures against its stated goal of bolstering local industrial capacity. The tender…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • SA’s HIV success story creates new challenges

    South Africa’s groundbreaking success in providing antiretroviral treatment (ARVs) to millions has transformed HIV from a death sentence into a manageable chronic condition. Many benefit from this. SA’s HIV success story is evident, with roughly 6 million people now on ARVs in the public sector since the 2004 scale-up. This allows people living with HIV to live longer, healthier lives,…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in